Regulated in development and DNA damage responses -1 (REDD1) protein contributes to insulin signaling pathway in

Claire Regazzetti1, Karine Dumas, Yannick Le Marchand-Brustel

  • 1INSERM U 1065, Mediterranean Research Centre for Molecular Medicine, Team: Cellular and Molecular Physiopathology of obesity and diabetes, Nice, France.

Plos One
|December 29, 2012
PubMed

Insights

Regulated in development and DNA damage response 1 (REDD1) positively impacts insulin signaling. Insulin boosts REDD1 expression, which then inhibits mTORC1, enhancing the insulin pathway and lipogenesis.

Area of Science:

  • Cellular biology
  • Molecular endocrinology
  • Metabolic signaling

Background:

  • Regulated in development and DNA damage response 1 (REDD1) is a known hypoxia and stress response gene.
  • REDD1 acts as a negative regulator of the mechanistic target of rapamycin complex 1 (mTORC1).
  • mTORC1 plays a role in the negative feedback loop of insulin signaling.

Purpose of the Study:

  • To investigate the role of REDD1 in the insulin signaling pathway.
  • To determine how insulin regulates REDD1 expression and function.

Main Methods:

  • Insulin stimulation assays in human and murine adipocytes and HEK-293 cells.
  • MEK pathway analysis and manipulation.
  • REDD1 silencing using siRNA in 3T3-L1 adipocytes.
  • Assessment of mTORC1 activity and insulin signaling components.
  • Proteasomal degradation studies involving CUL4A-DDB1 ubiquitin ligase complex.

Main Results:

  • Insulin transiently stimulates REDD1 expression via a MEK-dependent pathway in adipocytes.
  • Active MEK stabilizes REDD1, protecting it from proteasomal degradation.
  • REDD1 downregulation increases mTORC1 activity and inhibits insulin signaling and lipogenesis.
  • Rapamycin treatment restores insulin signaling following REDD1 downregulation.

Conclusions:

  • REDD1 positively regulates insulin signaling by inhibiting mTORC1 activity.
  • Insulin-induced REDD1 expression is a key component of the biological response to insulin.
  • REDD1 acts as a crucial link between insulin stimulation and metabolic outcomes.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...